Structure of Human CD335/NCR1/NKp46 HEK293T Stable Cell Line
The Human CD335/NCR1/NKp46 HEK293T Stable Cell Line is a unique cell line that has been engineered to stably express the human CD335 (also known as NCR1 or NKp46) protein. This protein is a natural killer (NK) cell receptor that plays a critical role in the innate immune response against viral infections and tumor cells. The cell line is derived from HEK293T cells, a human embryonic kidney cell line that is commonly used in research for its high transfection efficiency and ability to support the growth of a wide range of viruses. The stable expression of CD335 in these cells allows for the study of its structure, activity, and potential therapeutic applications.
Activity of Human CD335/NCR1/NKp46 HEK293T Stable Cell Line
The primary activity of the Human CD335/NCR1/NKp46 HEK293T Stable Cell Line is the expression of the CD335 protein. This protein belongs to the natural cytotoxicity receptor (NCR) family, which also includes CD336 (NKp44) and CD337 (NKp30). These receptors are expressed on the surface of NK cells and play a crucial role in their activation and function. CD335 specifically recognizes viral hemagglutinins and tumor cell ligands, leading to the activation of NK cells and subsequent killing of infected or malignant cells.
In addition to its role in NK cell activation, CD335 has also been shown to play a role in the regulation of cytokine production and immune cell recruitment. Studies have demonstrated that CD335 can induce the production of cytokines such as interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α), which are important for antiviral and antitumor responses. Furthermore, CD335 can also modulate the migration and activation of other immune cells, such as dendritic cells and T cells, through interactions with its ligands.
Application of Human CD335/NCR1/NKp46 HEK293T Stable Cell Line
The Human CD335/NCR1/NKp46 HEK293T Stable Cell Line has a wide range of potential applications in both basic research and therapeutic development. One of the primary uses of this cell line is in the study of the structure and function of CD335. Its stable expression in HEK293T cells allows for the purification and characterization of the protein, which can provide valuable insights into its role in immune responses and potential therapeutic applications.
Another important application of this cell line is in the development of novel immunotherapies. CD335 has been identified as a promising therapeutic target for the treatment of viral infections and various types of cancer. The stable expression of CD335 in HEK293T cells enables the screening and identification of potential therapeutic agents that can modulate its activity. Additionally, this cell line can serve as a valuable tool for studying the mechanisms of action of these potential therapeutics.
The Human CD335/NCR1/NKp46 HEK293T Stable Cell Line is also a valuable resource for studying the immune response to viral infections and tumors. By expressing CD335, these cells can mimic the activation and function of NK cells in response to viral or malignant stimuli. This cell line can be used to investigate the role of CD335 in the immune response to specific viruses or tumors, as well as to test the efficacy of potential immunotherapies.
In conclusion, the Human CD335/NCR1/NKp46 HEK293T Stable Cell Line is a unique and versatile tool for studying the structure, activity, and potential therapeutic applications of the CD335 protein. Its stable expression in HEK293T cells allows for the investigation of the immune response to viral infections and tumors, as well as the identification and development of novel immunotherapies. With its potential to advance our understanding of the immune system and its role in disease, this cell line holds great promise for future research and therapeutic development.
There are no reviews yet.